SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: A.J. Mullen who wrote (112)11/3/2003 5:35:46 PM
From: Biomaven  Respond to of 411
 
I thought an AC meeting was the norm.

Nope. Only have an AC meeting for something very novel or where the FDA thinks they need guidance. I'd say about half the time there is no AC meeting.

I'd be surprised if the Qtc issue is what the FDA is concerned about - I suspect that's a red herring.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News